Iridex to Present at the 2021 H.C. Wainwright Ophthalmology Virtual Conference

Rhea-AI Summary

IRIDEX Corporation (Nasdaq: IRIX) has announced its participation in the upcoming H.C. Wainwright Ophthalmology Virtual Conference set for August 17, 2021. The company specializes in innovative ophthalmic laser-based medical products aimed at treating conditions such as glaucoma and retinal diseases. David Bruce, the President and CEO, is scheduled to present at 7:00 am ET. Interested parties can access the live and archived webcast through iridex.com.

The company is recognized for its MicroPulse® technology, enhancing treatments for eye conditions worldwide.

MOUNTAIN VIEW, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming H.C. Wainwright Ophthalmology Virtual Conference.

David Bruce, Iridex’s President and Chief Executive Officer, is scheduled to present on Tuesday, August 17, 2021, at 7:00 am ET. Interested parties may access a live and archived webcast of the presentation at http://www.iridex.com.

About IRIDEX
Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit www.iridex.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
investors@iridex.com

FAQ

When is IRIDEX scheduled to present at the H.C. Wainwright Ophthalmology Virtual Conference?

IRIDEX is scheduled to present on August 17, 2021, at 7:00 am ET.

How can I access the IRIDEX presentation at the ophthalmology conference?

You can access the live and archived webcast of the presentation at iridex.com.

What technologies does IRIDEX specialize in?

IRIDEX specializes in laser-based medical products for treating glaucoma and retinal diseases.

What is the significance of MicroPulse® technology by IRIDEX?

MicroPulse® technology offers a safe and effective treatment for targeted sight-threatening eye conditions.

In which countries does IRIDEX sell its products?

IRIDEX products are sold in the United States, Germany, and over 100 other countries.